Automated Compounding Devices Market Analysis, Demand And Outlook 2025- 2034

Get 20% Off All Market Studies With Code ONLINE20 – Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends

What Is the Forecasted Market Size of the Automated Compounding Devices Market by 2029?
The automated compounding devices market size has grown strongly in recent years. It will grow from $2.36 billion in 2024 to $2.51 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, an aging population, the expansion of healthcare infrastructure, regulatory requirements, and increasing medication errors.

The automated compounding devices market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising cancer prevalence, global healthcare expansion, increased focus on patient safety, regulatory support, and an and an increasing focus on sustainability. Major trends in the forecast period include telemedicine, remote healthcare, advancements in artificial intelligence, healthcare digitalization, and real-time monitoring.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp

What Are the Major Drivers Influencing the Automated Compounding Devices Market?
The increasing number of personalized medicines is expected to fuel the growth of the automated compounding devices market going forward. Personalized medicine refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to the individual characteristics of each patient. The increasing number of personalized medicines is due to a better understanding of genetics, patient-specific data, and regulatory support. Automated compounding devices (ACDs) play a crucial role in the field of personalized medicine by enabling the precise and accurate preparation of custom medication formulations tailored to individual patient needs. These devices automate the process of combining various pharmaceutical ingredients in specific proportions, which is essential for creating personalized treatments. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the increasing number of personalized medicines is driving the growth of the automated compounding devices market.

Which Are the Leading Segments in the Automated Compounding Devices Market by Revenue?
The automated compounding devicesmarket covered in this report is segmented –

1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software
2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)
2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems

Which Trends Are Positively Affecting the Automated Compounding Devices Market Expansion?
Major companies operating in the automated compounding device market are focusing on reducing medication errors and improving patient safety with advanced technologies, such as robotic compounding technology, to gain enhanced customer trust, regulatory compliance, and a competitive advantage. Robotic compounding technology automates the precise preparation and mixing of pharmaceutical compounds using advanced robotic systems, enhancing accuracy, efficiency, and safety in medication preparation. For instance, in March 2022, Omnicell Inc., a US-based healthcare technology company, launched the IVX Station, a new automated compounding device. This innovative solution aims to expand access to IV robotic technology in the broader market, enhancing patient safety, accuracy, cost efficiency, supply chain management, and regulatory compliance. The IVX Station offers three times faster throughput than current IV robotic systems, incorporates a highly reliable design to minimize downtime, and maintains a compact footprint suitable for pharmacy operations.

Who Are the Leading Players in the Automated Compounding Devices Market?
Major companies operating in the automated compounding devices market are McKesson Corporation, Amerisource Bergen Corporation, Medtronic PLC, Becton Dickinson and Company, Baxter International Inc, B. Braun Melsungen AG, Fresenius Kabi AG, Grifols International S.A., Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Cantel Medical Corp., Fagron N.V., Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group S.p.A., ARxIUM Inc., Codonics Inc., Apexus Inc., Equashield LLC, Yuyama Mfg Co. Ltd., Shanghai Weibond Technology Co. Ltd., Quirem Medical B.V

Get the full automated compounding devices market report here:
https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

What Are the Opportunities and Challenges for Automated Compounding Devices Market Across Regions?
North America was the largest region in the automated compounding devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company